medicare part d plan

Medicare Part D
Prescription Drug Coverage 2026

Find a Medicare Part D prescription drug plan

Advertisement

Medicare Part D Plans 2026

Shopping for next year? Enrollment for 2027 coverage runs from October 15 to December 7, 2026. See the Medicare Part D plans 2027 guide for the $700 deductible, the $2,400 out-of-pocket cap, and why premiums are rising.

Curious about the changes coming to Medicare Part D Plans 2026?

You’ll see higher deductibles, new out-of-pocket limits, and better catastrophic coverage. These updates, driven by the Inflation Reduction Act, aim to make medications more affordable and accessible. Read on to find out everything you need to know.

 

Key Takeaways

  • In 2026, the standard initial deductible for Medicare Part D will increase to $615, while the out-of-pocket spending limit rises to $2,100, impacting beneficiaries’ costs during the coverage phases.
  • The Inflation Reduction Act introduces critical updates, including a $35 cap on monthly insulin costs, expanded vaccine coverage, and a drug price negotiation program aiming to reduce expenses for high-cost medications.
  • Enrollment in Medicare Advantage plans is on the rise, with more than half of eligible beneficiaries participating, driven by benefits such as lower costs and integrated services compared to standalone Prescription Drug Plans.

Overview of Medicare Part D Plans for 2026

 

Overview of Medicare Part D Plans for 2026

Medicare Part D plans are evolving to better serve beneficiaries in 2026, with a focus on improving affordability and access to necessary medications. A significant update is the increase in the standard initial deductible from $590 in 2025 to $615 in 2026. This adjustment reflects the ongoing efforts to balance the costs and benefits within the Medicare prescription payment plan program.

Additionally, beneficiaries will see adjustments in their out-of-pocket spending limits and enhanced coverage during the catastrophic phase. These changes are influenced by the Inflation Reduction Act, which aims to lower prescription drug costs and provide enhanced benefits for enrollees.

The following sections will break down these updates in more detail.

 

Standard Initial Deductible Increase

In 2026, the Medicare Part D standard initial deductible will increase to $615 from $590 in 2025. This change impacts the out-of-pocket costs for beneficiaries during the initial coverage phase, a critical component of the defined standard benefit.

This deductible adjustment aims to balance program sustainability with quality drug coverage standards.

 

Out-of-Pocket Spending Limit Adjustment

The out-of-pocket spending limit for Medicare Part D will rise to $2,100 in 2026, up from $2,000. The new cap sets a clear limit on out-of-pocket costs for covered Part D drugs at $2,100.

This new out-of-pocket spending cap will take effect on January 1, 2026, offering Medicare beneficiaries a more predictable and manageable cost-sharing structure. These updates support the Medicare program’s broader goal of making medications affordable and accessible.

 

Catastrophic Coverage Phase Benefits

Starting January 1, 2024, Medicare beneficiaries will benefit from zero cost-sharing for formulary drugs during the Catastrophic Coverage phase. This significant change means that once enrollees reach the catastrophic threshold, they will not have to pay out-of-pocket for covered formulary medications, enhancing the Part D benefit and easing the financial burden on those with high prescription drug costs.

 

Key Updates Under the Inflation Reduction Act

 

Key Updates Under Inflation Reduction Act

The Inflation Reduction Act brings several key updates to Medicare Part D in 2026, targeting improved coverage options and affordability for beneficiaries. These changes include a cap on insulin costs, expanded vaccine coverage, and a new drug price negotiation program. These updates are designed to provide significant financial relief and better access to essential medications.

The Inflation Reduction Act targets high prescription drug costs and expands covered services to positively impact Medicare beneficiaries. The following subsections will provide detailed insights into these crucial updates.

 

Insulin Cost Cap

One of the most impactful changes under the Inflation Reduction Act is the introduction of a cap on insulin costs. Starting in 2026, Medicare will limit insulin costs to $35 per month, significantly easing the financial burden for beneficiaries managing diabetes.

This cap applies to both Part D and Part B coverage, ensuring comprehensive support for insulin users across the Medicare program.

 

Expanded Vaccine Coverage

Medicare Part D’s expanded vaccine coverage will include additional vaccines such as those for shingles and whooping cough starting in 2026. These vaccines will be available at no out-of-pocket cost to beneficiaries, enhancing preventive care and protecting more individuals from preventable diseases.

 

Drug Price Negotiations

The Medicare drug price negotiation program aims to lower costs for select high-cost drugs starting in 2026, offering anticipated savings of $1.5 billion for beneficiaries. This program will target 15 Part D drugs initially, chosen based on their total gross covered prescription drug costs. Negotiating maximum fair prices is intended to make essential medications more affordable for enrollees.

However, the program faces legal challenges, with several lawsuits questioning its constitutionality. Despite these hurdles, the negotiation program represents a significant step towards reducing prescription drug costs and improving the financial well-being of Medicare beneficiaries.

See plans in your area instantly!

Advertisement

SPEAK WITH A LICENSED INSURANCE AGENT!

1-866-930-4039

 

TTY 711


Mon-Fri: 8am – 8pm EST

Enhanced Risk Adjustment Model for Part D

Enhanced Risk Adjustment Model for Part D

The enhanced risk adjustment model for Medicare Part D began phasing in in 2026 and runs over three years. It is how CMS calculates accurate plan bids under the redesigned benefit created by the Inflation Reduction Act, using revised risk corridors and a multiple linear regression methodology to improve payment accuracy.

The model balances potential gains and losses for Part D sponsors, which helps stabilize premiums for beneficiaries. The goal is to keep the Medicare program sustainable without pricing enrollees out of drug coverage.

 

Multiple Linear Regression Methodology

CMS uses a multiple linear regression methodology to calculate normalization factors for risk adjustment in the Part D model. The approach integrates five years of historical fee-for-service risk scores, which improves the accuracy and fairness of payments across the Medicare Part D program.

 

Impact on Premiums and Payments

For 2026, CMS set the Part D base beneficiary premium at $38.99 and the national average monthly bid amount at $239.27. Standalone drug plans also received a uniform $10 per member per month reduction to the base beneficiary premium, down from $15 in 2025.

A second protection caps how much any single plan can raise its total Part D premium year over year. That cap is $50 for 2026, up from $35 in 2025. Together these measures held 2026 standalone drug plan premiums far below what the raw bids would otherwise have produced.

 

The Premium Stabilization Demonstration Is Ending

CMS announced on July 28, 2026 that the Part D Premium Stabilization Demonstration will conclude on December 31, 2026, one year earlier than originally scheduled. CMS says plan sponsors now have enough experience pricing the redesigned benefit that the temporary subsidy is no longer needed.

This matters for anyone enrolled in a standalone Prescription Drug Plan. The $10 monthly subsidy and the $50 increase cap both disappear after 2026. The Part D base beneficiary premium rises to $41.33 for 2027, about 6 percent higher than 2026, and CMS projects that most standalone plan enrollees will see individual premium increases of less than $10 per month.

If you are in a standalone drug plan, compare your options during the Annual Enrollment Period rather than letting your plan renew automatically. Plans that leaned heavily on the subsidy are the most likely to reprice.

 

Revised Risk Corridors

Revised risk corridors remain a key part of the risk adjustment model and improve the predictability of costs for Medicare Part D plans. They limit how much a sponsor can gain or lose relative to its bid, which reduces the incentive to price defensively and keeps premiums closer to actual expected cost.

 

Low-Income Subsidy (LIS) Program Adjustments

 

Eligibility Criteria for Full Low-Income Subsidy

The Low-Income Subsidy, also called Extra Help, is the program that makes Medicare Part D affordable for people with limited income and resources. It can cover your drug plan premium, eliminate your deductible, and cut your copays to a few dollars per prescription.

Extra Help is unaffected by the demonstration ending, so if you qualify, your costs in 2026 and into 2027 stay protected. The sections below cover who qualifies and what the limits are.

 

Eligibility Criteria

To qualify for the full Low-Income Subsidy in 2026, your income must fall below 150% of the Federal Poverty Level. In the 48 contiguous states and DC that works out to roughly $24,180 per year for an individual and $32,700 per year for a married couple living together.

Alaska and Hawaii use higher thresholds. Income counted toward the limit also reflects a $20 monthly disregard, so you may still qualify even if your gross income looks slightly over the line. Apply through Social Security rather than assuming you are ineligible.

 

Resource Limits

Resources also count. In 2026, the limit is $16,590 for an individual and $33,100 for a married couple. Those figures rise to $18,090 and $36,100 when you include the standard $1,500 per person burial allowance.

Countable resources include bank accounts, stocks and bonds. They do not include your home, your car, personal belongings, or a burial plot. A significant number of people who would qualify never apply because they assume their savings disqualify them.

 

Medicare Advantage and Part D Integration

Medicare Advantage plans that build in Part D drug coverage continue to gain ground. More than half of the eligible Medicare population is now enrolled in Medicare Advantage, reflecting a shift toward plans that bundle hospital, medical and prescription coverage into a single package rather than pairing Original Medicare with a separate drug plan.

Integration often means lower total costs and extra benefits such as dental and vision. It also means a narrower network and a single plan controlling both your medical and drug coverage, which is the tradeoff to weigh.

 

MA-PDs vs. Standalone PDPs

Medicare Advantage Prescription Drug plans (MA-PDs) often carry lower overall costs than standalone Prescription Drug Plans, and many are available with a $0 plan premium. They typically add benefits a standalone drug plan cannot offer, such as dental and vision coverage.

Standalone PDPs remain the right choice if you want to keep Original Medicare, or if you carry a Medicare Supplement policy and need drug coverage alongside it. With the premium stabilization subsidy ending after 2026, standalone plan premiums deserve a closer look during this year’s Annual Enrollment Period.

Find a Plan and Enroll Online Yourself!

Advertisement

OR SPEAK WITH A LICENSED INSURANCE AGENT

1-866-930-4039

 

TTY 711


Mon-Fri: 8am – 8pm EST

Enrollment Trends

Enrollment in Medicare Advantage plans has been steadily increasing, with 32.8 million individuals enrolled by 2024, accounting for 54% of the eligible Medicare population. This trend is expected to continue, with projections indicating that 64% of Medicare beneficiaries will choose Medicare Advantage plans by 2034.

The robust market offering approximately 43 plans per beneficiary reflects this growth.

 

When the 2026 Part D Changes Took Effect

 

Effective Dates for New Policies

Every 2026 Medicare Part D change took effect on January 1, 2026. Plans have been operating under the $615 standard deductible and the $2,100 annual out-of-pocket cap since the start of the year, so those are the amounts applied to your current drug coverage.

There is no coverage gap to worry about. The donut hole was eliminated in 2025, and once your out-of-pocket spending reaches $2,100 you pay nothing more for covered drugs for the rest of the calendar year.

 

Medicare Part D Prescription Coverage Made Simple

Finding the right Medicare Part D plan doesn’t have to be confusing. Get coverage for your medications and avoid high out-of-pocket costs next year.

Our licensed agents can help you compare options and choose a plan that fits your prescriptions perfectly.

Call 1-866-930-4039 now to review your 2026 drug coverage.

 

Frequently Asked Questions

  • What is the standard Initial Deductible for Medicare Part D in 2026?

The standard Initial Deductible for Medicare Part D in 2026 is $615, up from $590 in 2025.

 

  • What is the out-of-pocket spending limit (RxMOOP) for Medicare Part D in 2026?

The annual out-of-pocket spending limit for Medicare Part D in 2026 is $2,100, up from $2,000 in 2025. Once you reach it, you pay nothing more for covered drugs for the rest of the year.

 

  • What change occurred to the Initial Coverage Limit (ICL) in 2025?

The Initial Coverage Limit (ICL) was eliminated in 2025 and replaced by the annual drug maximum out-of-pocket spending limit (RxMOOP). This change gives you more predictable out-of-pocket costs for prescription drugs.

 

  • Can I still spread my Medicare Part D costs across the year?

Yes. The Medicare Prescription Payment Plan lets you spread your out-of-pocket drug costs into capped monthly payments across the calendar year instead of paying large amounts at the pharmacy counter. Participation is voluntary and you must opt in through your Part D plan.

 

  • What methodology is used for the Part D risk adjustment model?

The Part D risk adjustment model uses a multiple linear regression methodology to determine normalization factors, integrating five years of historical fee-for-service risk scores to improve accuracy.

Begin Choosing your plan

Advertisement

CALL TO SPEAK WITH A LICENSED INSURANCE AGENT

1-866-930-4039

 

TTY 711


Mon-Fri: 8am – 8pm EST

ZRN Health & Financial Services, LLC, a Texas limited liability company.